Stock Markets May 27, 2026 09:01 AM

Momentus Raises $25M in Private Placement; Shares Rally 26%

At-the-market offering from existing institutional backers boosts liquidity to roughly $76 million ahead of planned closing late May

By Nina Shah
Share
Twitter Reddit Facebook LinkedIn
MNTS

Momentus Inc. said it entered into agreements to sell 2,942,000 shares of common stock in a $25 million private placement to existing institutional investors. The at-the-market offering, arranged by A.G.P./Alliance Global Partners, is expected to close on or about May 28, 2026, subject to customary closing conditions. The company said combined with existing capital, the net proceeds will leave it with about $76 million in cash, cash equivalents, and short-term investments, and that proceeds will be used for working capital, research and development, strategic business initiatives, and general corporate purposes.

Momentus Raises $25M in Private Placement; Shares Rally 26%
MNTS
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Momentus agreed to sell 2,942,000 shares in a $25 million private placement priced at-the-market under Nasdaq rules.
  • The offering is expected to close on or about May 28, 2026, and is subject to customary closing conditions.
  • Following the transaction, Momentus expects to hold approximately $76 million in cash, cash equivalents, and short-term investments to support working capital, R&D, strategic initiatives, and general corporate purposes.

Momentus Inc. (NASDAQ:MNTS) reported a $25 million private placement of common stock to several of its existing institutional investors, a move that coincided with a 26% rise in the company's share price on Wednesday.

The company entered into securities purchase agreements to sell 2,942,000 shares, with the shares to be offered at-the-market under Nasdaq rules. The company indicated the transaction is expected to close on or about May 28, 2026, and remains subject to customary closing conditions.

Momentus said it intends to apply the net proceeds to working capital and general corporate purposes. The company further detailed that, when combined with existing capital, the cash, cash equivalents, and short-term investments on its balance sheet are expected to be approximately $76 million following the closing of this placement.

In a statement accompanying the financing announcement, Momentus' chairman and chief executive officer said the participation by existing investors demonstrates continued support for the company's mission and that the proceeds will be directed to research and development, investment in strategic business initiatives, and other corporate needs.

A.G.P./Alliance Global Partners is acting as the sole placement agent for the offering.

The financing is structured as a capital raise from fundamental institutional investors already affiliated with the company. The transaction provides incremental funding intended to support Momentus' operations and its strategic initiatives in space solutions and in-space transportation.


Context and operational positioning

By completing this at-the-market private placement, Momentus aims to bolster near-term liquidity. The company has specified several categories for the use of proceeds - working capital, research and development, strategic initiatives, and general corporate purposes - but has not provided a detailed allocation of funds within those categories.

The expected closing date, on or about May 28, 2026, is noted as contingent on customary closing conditions, which introduces timing uncertainty until the transaction is completed.


Market reaction

Shares of Momentus climbed 26% on the day of the announcement, reflecting investor response to the financing and the explicit backing from the company's existing institutional shareholders.


Financial intermediaries

A.G.P./Alliance Global Partners is serving as sole placement agent for the offering, coordinating the sale of common stock on behalf of Momentus to the participating institutional investors.

Risks

  • The planned closing is subject to customary closing conditions, introducing uncertainty around timing and finalization of the $25 million placement.
  • The company has stated broad categories for use of proceeds - working capital, research and development, strategic initiatives, and general corporate purposes - but has not provided a detailed allocation, leaving the precise deployment of funds unspecified.
  • The offering is an at-the-market sale of common stock, which means the number of shares and the pricing are tied to market conditions at the time of sale.

More from Stock Markets

Analyst Moves This Week: Value Plays, Activist Triggers and Tech-Driven Upside Jun 7, 2026 Middle Eastern Airlines Advised Against Postponing Jet Purchases Despite Iran War Disruption Jun 6, 2026 Morgan Stanley Identifies Four Emerging Revenue Streams That Could Reframe Meta’s AI Investment Case Jun 6, 2026 Frasers Group Weighs £500m Offer for Metrocentre as Property Buying Spree Continues Jun 6, 2026 FDA Grants Orphan Drug Status to Merck’s Pembrolizumab for Neuroendocrine Prostate Cancer Jun 6, 2026